Acute Coronary Syndrome
Conditions
Brief summary
This prospective cohort study is aimed at identification and risk stratification of patients who have symptoms of acute chest pain suspected with acute coronary syndrome （ACS） using Magnetocardiography （MCG）.
Interventions
DEVICEMagnetocardiography
Magnetocardiography
Sponsors
Chongqing Emergency Medical Center
Weifang People's Hospital
Linyi People's Hospital
Weihai Central Hospital
Jining First People's Hospital
The First Affiliated Hospital with Nanjing Medical University
Second Affiliated Hospital, School of Medicine, Zhejiang University
First Affiliated Hospital Xi'an Jiaotong University
First People's Hospital of Hangzhou
Guangdong Provincial Hospital of Traditional Chinese Medicine
Qianfoshan Hospital
Heze Municipal Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Qilu Hospital of Shandong University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Those with suspected ACS who presented with symptoms of acute chest pain. * Signed informed consent.
Exclusion criteria
* Those with known structural heart disease such as cardiomyopathy and valvular disease; * Those with atrial fibrillation, supraventricular tachycardia, atrioventricular block and other arrhythmias that have not returned to normal; * Those who have chest pain with known pulmonary embolism or aortic coarctation; * Those who are thought to be incapable of completing the MCG examination by an attending physician (or physician with higher qualifications) due to unstable clinical conditions, metal implants, etc; * Those who are unable to perform magnetocardiography examinations due to claustrophobia, etc., or those who fail to receive magnetocardiography examination; * Those with malignant tumors; * Pregnant or lactating women. * Those with acute or critical illnesses of other systems, such as acute or severe respiratory illnesses, marked abnormalities in liver function or kidney function.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Efficacy of MCG for the detection and risk stratification in high-risk patients with chest pain | from the date of enrollment until the date of discharge, up to 30 days | Establishing an algorithm model of MCG in identifying high-risk cardiogenic chest pain, the efficacy of the model was assessed by sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and AUC, etc. |
| Efficacy of MCG for the detection and risk stratification in low-risk patients with chest pain | from the date of enrollment until the date of discharge, up to 30 days | Establishing an algorithm model of MCG in identifying low-risk cardiogenic chest pain, the efficacy of the model was assessed by sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and AUC, etc. |
Countries
China
Contacts
Primary ContactJiaojiao Pang, Doctor
Outcome results
None listed